SCA
CELG

Strategic Capital Alternatives’s Celgene Corp CELG Stock Holding History

Strategic Capital Alternatives’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1.74M Buy
16,054
+10,322
+180% +$1.28M 0.37% 84
2015
Q2 		$663K Buy
+5,732
New +$655K 0.16% 120
2014
Q4 		– Sell
-918
Closed -$87K – 409
2014
Q3 		$87K Buy
+918
New +$82.8K 0.03% 183

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Strategic Capital Alternatives's CELG Position: Q3 2015 in Review

Strategic Capital Alternatives increased its Celgene Corp (CELG) stake by 180% in Q3 2015, buying an estimated $1.28M and bringing the position to 16,054 shares worth $1.74M. The position accounts for 0.37% of the portfolio, ranked #84.

Strategic Capital Alternatives first reported a position in CELG in Q3 2014 and has held it in 3 quarters since. 1,196 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

  • Strategic Capital Alternatives held 16,054 shares of Celgene Corp worth $1.74M as of Q3 2015.
  • Strategic Capital Alternatives bought 10,322 Celgene Corp shares in Q3 2015, an estimated $1.28M.
  • Celgene Corp made up 0.37% of Strategic Capital Alternatives's portfolio in Q3 2015, its #84 holding.
  • Strategic Capital Alternatives first reported a position in Celgene Corp in Q3 2014 and has held it in 3 quarters since.
  • 1,196 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.